PEMDOTLS: Preclinical evaluation of Miltefosin derivatives optimised for the treatment of Leishmaniasis and Sleep Disease. (Q2906826): Difference between revisions

@@ Property / budget @@
+,000.0 EuroAmount 240,000.0 Euro
Unit Euro
-Amount
+,000.0 Euro
-Unit
+Euro
@@ Property / budget: 240,000.0 Euro / rank @@
+Normal rank
@@ Property / EU contribution @@
+,000.0 EuroAmount 204,000.0 Euro
Unit Euro
-Amount
+,000.0 Euro
-Unit
+Euro
@@ Property / EU contribution: 204,000.0 Euro / rank @@
+Normal rank
@@ Property / co-financing rate @@
+.0 percentAmount 85.0 percent
Unit percent
-Amount
+.0 percent
-Unit
+percent
@@ Property / co-financing rate: 85.0 percent / rank @@
+Normal rank

Revision as of 22:31, 21 October 2021

Project Q2906826 in Portugal

Language	Label	Description	Also known as
English	PEMDOTLS: Preclinical evaluation of Miltefosin derivatives optimised for the treatment of Leishmaniasis and Sleep Disease.	Project Q2906826 in Portugal